Key indicators: single-crystal X-ray study; T = 273 K; mean (C-C) = 0.004 Å; R factor = 0.048; wR factor = 0.123; data-to-parameter ratio = 13.8.
The title compound, C 10 H 11 NO 4 S, is of interest with respect to its biological activity. The molecules are linked into centrosymmetric dimers by intermolecular O-HÁ Á ÁO hydrogen bonds and the dimers are further connected into chains by weak C-HÁ Á ÁO interactions.
Related literature
For related literature on fibrate structures and biological activity, see: Henry et al. (2003) ; Rath et al. (2005) ; Djinović et al. (1989) ; Thorp (1962) ; Thorp & Waring (1962) ; Miller & Spence (1998) ; Forcheron et al. (2002) . For related literature, see: Bernstein et al. (1995) ; Desiraju (2002) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). Symmetry codes: (i) Àx þ 1; Ày; Àz þ 2; (ii) x þ 1; y; z.
Data collection: SMART (Bruker, 2000) ; cell refinement: SAINTPlus NT (Bruker, 2000) ; data reduction: SAINT-Plus NT; program(s) used to solve structure: SHELXS97 (Sheldrick, 1997); program(s) used to refine structure: SHELXL97 (Sheldrick, 1997); molecular graphics: SHELXTL-NT (Bruker, 2000) ; software used to prepare material for publication: PLATON (Spek, 2003) and publCIF (Westrip, 2007 (Henry et al., 2003; Rath et al., 2005; Djinović et al., 1989) , which are ligands for the nuclear receptor PPAR (peroxisome proliferator-activated receptor), are used as therapeutic agents in the treatment of hyperlipidemia, heart disease and diabetic complications in humans. The fibrates are a widely used class of lipid-modifying agents that decrease plasma triglycerides (Thorp, 1962; Miller & Spence, 1998; Forcheron et al., 2002) . The fibric acid pharmacophore has been of interest to medicinal chemists ever since the initial discovery that ethyl chlorophenoxyisobutyrate possessed hypolipidemic properties (Thorp & Waring, 1962) .
In order to assist our knowledge about the electronic and steric requirements for such compounds to to show antihyperlipidemic activity, we have determined the crystal structure of the title compound, (I), which is an analogue of clofibric acid with a thioisobutirate side chain. A view of the molecular structure of (I) and hydrogen bonded dimers is given in Fig. 1 . The crystal structure is permeated by strong O-H···O hydrogen-bonding interactions, as well as weak C-H···O interactions (Tablel 1) (Desiraju, 2002) . The O-H···O hydrogen bonding interactions form centrosymmetric dimers and generate rings that can be described as having a graph set motif of R 2 2 (8) (Bernstein et al., 1995) .
A mixture of 4-nitrothiophenol (1.0 g, 6.40 mmol), potassium carbonate (1.94 g, 14.1 mmol) in acetonitrile, was added dropwise to 1.04 ml of ethyl 2-bromo-2-methylpropionate (1.37 g, 7.04 mmol). The mixture was stirred and heated under reflux for 6 h. After that, the mixture was poured onto cold water. The resulting oil was treated with a mixture of tetrahydrofuran/methanol/H 2 O (3:2:1, v/v/v, 6 ml/mmol), and LiOH was added (5 equiv). The mixture was stirred at room temperature for 3 h. Then, HCl solution (10% v/v) was added, and most of the organic solvents removed in vacuo. The partly solid residue was extracted with CH 2 Cl 2 (3 x 10 ml), dried with Na 2 SO 4 , filtered, and concentrated in vacuo to give a yellow solid (m.p. 394.9 K). Single crystals of (I) were obtained from acetonitrile.
Refinement
All the H atoms were constrained using the riding-model approximation [C-H aryl = 0.95 Å, U iso (H aryl ) = 1.2 U eq (C aryl );
C-H methyl = 0.98 Å, U iso (H methyl ) = 1.5U eq (C methyl )]; O-H = 0.82 Å, U iso (H hydroxyl ) = 1.5U eq (O)].
supplementary materials sup-2 Figures   Fig. 1 . The molecular structure of (I) showing 50% probability displacement ellipsoids and the atomic numbering. H atoms are shown as small spheres of arbitrary radius. The intermolecular hydrogen bonds O4-H4···O3 forming the R 2 2 (8) motif are shown as dotted lines.
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